Advertisement
Research Article| Volume 3, ISSUE 5, P593-599, September 2014

Download started.

Ok

Associations between onset age and disability in multiple sclerosis patients studied using MSSS and a progression model

  • Sudarshan Ramachandran
    Affiliations
    Keele Multiple Sclerosis Research Group, Department of Neurology, University Hospital of North Staffordshire, Stoke-on-Trent, ST4 7LN Staffordshire, England, United Kingdom

    Department of Biochemistry, Good Hope Hospital, Heart of England Foundation Trust, Sutton Coldfield B75 7RR, England, United Kingdom
    Search for articles by this author
  • Richard C. Strange
    Affiliations
    Keele Multiple Sclerosis Research Group, Department of Neurology, University Hospital of North Staffordshire, Stoke-on-Trent, ST4 7LN Staffordshire, England, United Kingdom

    Institute for Science and Technology in Medicine, Keele University Medical School, Hartshill Campus, Stoke-on-Trent ST4 7QB, England, United Kingdom
    Search for articles by this author
  • Peter W. Jones
    Affiliations
    Keele Multiple Sclerosis Research Group, Department of Neurology, University Hospital of North Staffordshire, Stoke-on-Trent, ST4 7LN Staffordshire, England, United Kingdom

    Institute for Science and Technology in Medicine, Keele University Medical School, Hartshill Campus, Stoke-on-Trent ST4 7QB, England, United Kingdom
    Search for articles by this author
  • Seema Kalra
    Affiliations
    Keele Multiple Sclerosis Research Group, Department of Neurology, University Hospital of North Staffordshire, Stoke-on-Trent, ST4 7LN Staffordshire, England, United Kingdom

    Institute for Science and Technology in Medicine, Keele University Medical School, Hartshill Campus, Stoke-on-Trent ST4 7QB, England, United Kingdom
    Search for articles by this author
  • Devaki Nayak
    Affiliations
    Keele Multiple Sclerosis Research Group, Department of Neurology, University Hospital of North Staffordshire, Stoke-on-Trent, ST4 7LN Staffordshire, England, United Kingdom

    Institute for Science and Technology in Medicine, Keele University Medical School, Hartshill Campus, Stoke-on-Trent ST4 7QB, England, United Kingdom
    Search for articles by this author
  • Clive P. Hawkins
    Correspondence
    Correspondence to: Human Genomics Research Group, Keele University Medical School, University Hospital of North Staffordshire, Staffordshire ST4 7LN, England, United Kingdom.
    Affiliations
    Keele Multiple Sclerosis Research Group, Department of Neurology, University Hospital of North Staffordshire, Stoke-on-Trent, ST4 7LN Staffordshire, England, United Kingdom

    Institute for Science and Technology in Medicine, Keele University Medical School, Hartshill Campus, Stoke-on-Trent ST4 7QB, England, United Kingdom
    Search for articles by this author

      Highlights

      • Association between MS disability and onset age is different with symptom onset before and after an age range of 30–35 years.
      • Use of progression model to measure disability produced similar results to MSSS.
      • The progression model could be used as a replacement for the MSSS score if validated.

      Abstract

      Background

      While many factors have been examined, male gender and older age at multiple sclerosis onset are among few variables consistently associated with increased disability. Interestingly, the association between onset age and disability may not be linear with some data suggesting a faster rate of accumulation of disability in patients aged more than 30 years at onset.

      Objective

      Explore the relationship between onset age and disability.

      Methods

      We studied 500 MS patients grouped by cut-offs in onset age. Disability was assessed using Multiple Sclerosis Severity Scale (MSSS) and, a model based on time to reach an Extended Disability Severity Score (EDSS) (progression model). Data were analyzed using linear and logistic regression.

      Results

      The association between disability (assessed by both MSSS and the progression model) and onset age was different in patients whose MS onset occurred after an age band of 30–35 years. Before this age range, changing age was not associated with changes in disability while during and after this age range, disability was increased.

      Conclusion

      We found a significant change in the relationship between disability and onset age after about 31 years supporting the idea that while onset age does not define a sharp cut-off, it can help define subgroups of patients with differing rates of accumulation of disability.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Multiple Sclerosis and Related Disorders
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Confavreux C.
        • Vukusic S.
        • Adeleine P.
        Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.
        Brain. 2003; 126: 770-782
        • Confavreux C.
        • Vukusic S.
        Age at disability milestones in multiple sclerosis.
        Brain. 2006; 129: 595-605
        • Confavreux C.
        • Vukusic S.
        The clinical course of multiple sclerosis.
        Handb Clin Neurol. 2014; 122: 343-369
        • Dean G.
        • Kurtzke J.F.
        On the risk of multiple sclerosis according to age at immigration to South Africa.
        Br Med J. 1971; 3: 725-759
        • Hensiek A.E.
        • Sawcer S.J.
        • Compston D.A.
        Searching for needles in haystacks – the genetics of multiple sclerosis and other common neurological diseases.
        Brain Res Bull. 2003; 61: 229-234
        • Kurtzke J.F.
        A reassessment of the distribution of multiple sclerosis.
        Acta Neurol Scand. 1975; 51: 137-157
        • Kurtzke J.F.
        Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).
        Neurology. 1983; 33: 1444-1452
        • Lünemann J.D.
        • Kamradt T.
        • Martin R.
        • Münz C.J.
        Epstein–Barr virus: environmental trigger of multiple sclerosis?.
        Virology. 2007; 81: 6777-6784
        • Murray T.J.
        Diagnosis and treatment of multiple sclerosis.
        Br Med J. 2006; 332: 525-527
        • Partridge J.M.
        • Weatherby S.J.
        • Woolmore J.A.
        • Highland D.J.
        • Fryer A.A.
        • Mann C.L.
        • et al.
        Susceptibility and outcome in MS: associations with polymorphisms in pigmentation-related genes.
        Neurology. 2004; 62: 2323-2325
      1. Pena JA, Lotze TE. Pediatric multiple sclerosis: current concepts and consensus definitions. Autoimmune Dis 2013. 10.1155/2013/673947.

        • Ramachandran S.
        • Strange R.C.
        • Kalra S.
        • Nayak D.
        • Zeegers M.P.
        • Gilford J.
        • et al.
        Progression of disability in multiple sclerosis: a study of factors influencing median time to reach an EDSS value.
        Mult Scler Relat Disord. 2012; 2: 109-116
        • Roxburgh R.H.
        • Seaman S.R.
        • Masterman T.
        • Hensiek A.E.
        • Sawcer S.J.
        • Vukusic S.
        • et al.
        Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.
        Neurology. 2005; 64: 1144-1151
        • Trojano M.
        • Avolio C.
        • Manzari C.
        • Calò A.
        • De Robertis F.
        • Serio G.
        • et al.
        Multivariate analysis of predictive factors of MS with a validated method to assess clinical events.
        J Neurol Neurosurg Psychiatry. 1995; 58: 300-306
        • Weinshenker B.G.
        • Bass B.
        • Rice G.P.
        • Noseworthy J.
        • Carriere W.
        • Baskerville J.
        • et al.
        The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability.
        Brain. 1989; 112: 133-146
        • Weatherby S.J.M.
        • Thomson W.
        • Pepper L.
        • Donn P.
        • Worthington J.
        • Mann C.L.A.
        • et al.
        HLA-DRB1 and disease outcome in multiple sclerosis.
        J Neurol. 2001; 248: 304-310
        • Westberg M.
        • Feychting M.
        • Jonsson F.
        • Nise G.
        • Gustavsson P.
        Occupational exposure to UV light and mortality from multiple sclerosis.
        Am J Ind Med. 2009; 52: 353-357
        • Woolmore J.A.
        • Stone M.
        • Pye E.M.
        • Partridge J.M.
        • Boggild M.
        • Young C.
        • et al.
        Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiation.
        Mult Scler. 2007; 13: 369-375